Skip to main content

Find Clinical Trials

Home
Conditions
Type 2 Diabetes Mellitus

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)

NCT02411929

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes

NCT01404676

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)

NCT02226003

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

NCT02036515

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

NCT02099110

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

NCT03230786

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Diabetologická a Obezitologická ambulance České Budějovice, Czechia

Vdoviak Miroslav MUDr. - Interní Ambulance Karlovy Vary, Czechia

Interní a Diabetologická ambulance, Clintrial s.r.o Prague, Czechia

Endokrinologicky Ústav Prague, Czechia

View all 30 locations

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

NCT01755156

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)

NCT01704261

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)

NCT00673465

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

NCT01407276

Conditions: Chronic Disease, Chronic Renal Insufficiency, Diabetes Mellitus, +17 more
Locations: Not specified

View Trial Details